Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVAsION: Randomized study to evaluate 2LVERU JUNIOR and 2LVERU efficacy in the treatment of warts
2019-001443-52Phase 4Active
- Sponsor
- Labo'Life Belgium
- Start
- Jun 2019
- Modality
- Therapeutic Vaccines → Vaccines & Immunotherapeutics, RNA Therapeutics → Nucleic Acid Therapeutics, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of 2LVERU in verruca, plantar wart and flat wart (3 arms), sponsored by Labo'Life Belgium. Started Jun 2019; status: active.
02
Drugs
2LVERU
03
Conditions
verrucaplantar wartflat wart
Beyond the preview
Go deeper on 2019-001443-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001443-52.